Skip to main content
Log in

The cost associated with intraperitoneal versus subcutaneous administration of erythropoietin

  • Letters to the Editors
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Reddingius RE, Schröder CH, Monnens LA (1992) Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis. Eur J Pediatr 151:540–542

    Google Scholar 

  2. Sinai-Trieman L, Salusky IB, Fine RN (1989) Use of subcutaneous recombinant erythropoietin in children undergoing continuous cycling peritoneal dialysis. J Pediatr 114:550–554

    Google Scholar 

References

  1. Navarro M, Alonso A, Avilla JM, Espinosa L (1991) Anemia of chronic renal failure: treatment with erythropoietin. Child Nephrol Urol 11: 146–151

    Google Scholar 

  2. Scigalla P (1992) Effect of different routes of recombinant human erythropoietin (rhEPO) in children with end stage renal failure (ESRD). Proceedings of the ninth Congress of the International Pediatric Nephrology Association: 141A

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lane, W., Robson, M., Leung, A.K.C. et al. The cost associated with intraperitoneal versus subcutaneous administration of erythropoietin. Eur J Pediatr 152, 377 (1993). https://doi.org/10.1007/BF01956759

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01956759

Keywords

Navigation